跳至主要内容
临床试验/NCT00345306
NCT00345306暂停4 期

Artificial Endometrial Preparation for Frozen Thawed Embryo Transfer Applying Either Endometrin or Utrogestan - a Clinical Comparative Study

Hadassah Medical Organization4 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2007年3月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
暂停
入组人数
120
试验地点
4
主要终点
Pregnancy rates

研究概览

简要总结

The transfer of frozen-thawed embryos can be performed in a natural ovulatory cycle or in a hormonally manipulated cycle with a comparable pregnancy rate of 15%-20% per ET. When a hormonally modulated ET cycle is scheduled,an artificial endometrial preparation is carried out using estrogen stimulation followed by a concomitant progesterone treatment. Two progestative drugs are currently used in conventional IVF treatment, Utrogetan and Endometrin. Although Endometrin has been be efficiently used to support the luteal phase after embryo transfer in IVF cycles, currently, there is no study that assess its efficacy for clinical use in frozen-thawed ET cycles. The present study aims to compare the outcome of frozen thawed ET cycles when either Endometrin or Utrogestan are used as the progestative substitution in an artificially prepared endometrium.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients undergoing frozen thawed ET cycles
  • Patient has at least two embryos suitable for transfer after thawing
  • Age 18-35 years -

排除标准

  • Any known sensitivity to Endometrin or Utrogestan
  • Endometrial thickness less than 7.5 mm after estrogen priming -

结局指标

主要结局

Pregnancy rates

次要结局

  • Lutheal hormonal profile

研究者

申办方类型
Other

研究点 (4)

Loading locations...

相似试验